MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Rosetta Genomics Company Profile (NASDAQ:ROSG)

Consensus Ratings for Rosetta Genomics (NASDAQ:ROSG) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.33 (194.99% upside)

Analysts' Ratings History for Rosetta Genomics (NASDAQ:ROSG)
Show:
DateFirmActionRatingPrice TargetActions
3/28/2016AegisReiterated RatingBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Barrington ResearchLower Price TargetOutperform$5.00 -> $3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha